However, the results for A673, SK‐N‐MC, and TC‐32 cells, in which FGF2 or bortezomib alone had minor effects on long‐term cell viability but their association was highly toxic, highlight the therapeutic potential of this combination for inducing cancer cell death. Here, FGF2 is linked to cancer.